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Abstract. 
 
Exocytosis in yeast requires the assembly of
 
the secretory vesicle soluble 
 
N
 
-ethylmaleimide–sensi-
tive factor attachment protein receptor (v-SNARE)
Sncp and the plasma membrane t-SNAREs Ssop and
Sec9p into a SNARE complex. High-level expression of
mutant Snc1 or Sso2 proteins that have a COOH-termi-
nal geranylgeranylation signal instead of a transmem-
brane domain inhibits exocytosis at a stage after vesicle
docking. The mutant SNARE proteins are membrane
associated, correctly targeted, assemble into SNARE
complexes, and do not interfere with the incorporation
of wild-type SNARE proteins into complexes. Mutant
SNARE complexes recruit GFP-Sec1p to sites of exo-
cytosis and can be disassembled by the Sec18p ATPase.
Heterotrimeric SNARE complexes assembled from
both wild-type and mutant SNAREs are present in het-
erogeneous higher-order complexes containing Sec1p
that sediment at greater than 20S. Based on a structural
analogy between geranylgeranylated SNAREs and the
GPI-HA mutant inﬂuenza virus fusion protein, we pro-
pose that the mutant SNAREs are fusion proteins un-
able to catalyze fusion of the distal leaﬂets of the secre-
tory vesicle and plasma membrane. In support of this
model, the inverted cone–shaped lipid lysophosphati-
dylcholine rescues secretion from SNARE mutant cells.
Key words: secretion • exocytosis • yeast • fusion
pore • hemifusion
 
Introduction
 
Fusion of lipid bilayers is essential for a variety of funda-
mental biological processes including the entry of envel-
oped viruses into cells and intracellular membrane traffic.
Since there is a substantial energy barrier preventing spon-
taneous membrane fusion under physiological conditions,
biological membrane fusion is mediated by fusion pro-
teins. Fusion proteins have been identified and extensively
characterized for several enveloped viruses, but the iden-
tity of the fusion proteins for intracellular membrane fu-
sion has not been conclusively established. Intracellular
membrane fusion is a multistep process in which the two
membranes must be correctly targeted and docked before
fusion can occur. Many of the proteins implicated in the
process of membrane fusion function at the targeting and
docking stages. The most attractive candidate fusion pro-
 
teins are the members of the soluble 
 
N
 
-ethylmaleimide–
sensitive factor (NSF)
 
1 
 
attachment protein (SNAP) recep-
tor (SNARE) family (Sollner et al., 1993b; Skehel and
Wiley, 1998; Weber et al., 1998).
 
SNAREs were originally identified as membrane pro-
 
teins that bound to the ATPase NSF via its cofactor
 
a
 
-SNAP (Sollner et al., 1993b). For fusion to occur, a trans-
SNARE complex must assemble between v-SNAREs on a
transport vesicle and t-SNAREs on its fusion target
(Nichols et al., 1997). cis-SNARE complexes have also been
observed where both transmembrane domains are present
in the same membrane (Otto et al., 1997). These complexes
may be remnants of previous membrane fusion events or
may have simply assembled nonproductively. ATP hydroly-
sis by NSF leads to the disassembly of SNARE complexes
and primes t-SNAREs for subsequent assembly into trans-
SNARE complexes (Sollner et al., 1993a; Mayer et al., 1996;
Ungermann et al., 1998a). The core of a SNARE complex is
 
a four-stranded parallel 
 
a
 
-helical bundle (Sutton et al.,
1998). Transmembrane domains extending from the
COOH terminus of the bundle are anchored in both the
vesicle and target membranes (Hanson et al., 1997). The
core of the SNARE complex also includes helices from pro-
teins such as SNAP-25 that do not have a transmembrane
domain but are associated with membranes often via a co-
valently attached lipid (Hess et al., 1992).
The fact that membranes must be closely apposed to be
bridged by a trans-SNARE complex lends support to the
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notion that SNAREs function as fusion proteins. The data
on this issue, however, are conflicting. SNARE-dependent
fusion has been reconstituted with recombinantly expressed
proteins incorporated into liposomes (Weber et al., 1998).
However, it has also been reported that disassembly of
trans-SNARE pairs by Sec18p, the yeast NSF, can occur be-
fore the completion of fusion in an in vitro assay of vacuole
fusion (Ungermann et al., 1998b). To reconcile these obser-
vations, it has been suggested that the prefusion state of the
SNARE complex has low affinity and is thus not detectable
by standard assays (Chen et al., 1999).
For insight into how SNAREs might catalyze intracellu-
lar fusion, we have looked to the best understood form of
membrane fusion, that mediated by the hemagglutinin
(HA) protein of influenza virus (Bentz, 1993; White et al.,
1996). Internalization of the virus to acidic endosomes
triggers a conformational shift in HA2 resulting in inser-
tion of the fusion peptide into the endosomal membrane.
Fusion is thought to occur in two steps. First, the outer
leaflets join to yield a hemifusion intermediate. Then, the
inner leaflets join to form a fusion pore, which expands to
allow entry of the viral core into the cytoplasm. The glyco-
sylphosphatidylinositol (GPI)-HA mutant fusion protein
is defective at the transition from the hemifusion interme-
diate to complete fusion (Kemble et al., 1993). In GPI-
HA, the COOH-terminal transmembrane and cytoplasmic
domains of HA have been replaced by a GPI membrane
anchor. Unlike the COOH terminus of wild-type HA, the
GPI anchor of GPI-HA is not inserted through the hydro-
philic face of the cytoplasmic leaflet of the host cell. Thus,
the GPI anchor can diffuse through the lipidic stalk con-
necting the hemifused membranes. Addition of chlor-
promazine allows full fusion by GPI-HA (Melikyan et al.,
1997; Chernomordik et al., 1999). Chlorpromazine is a
membrane-permeant, inverted cone–shaped amphipath
that preferentially accumulates in the cytoplasmic leaflet
of the plasma membrane. In theory, adding chlorprom-
azine introduces positive curvature in the hemifusion dia-
phragm. This positive curvature then stabilizes small pores
that form spontaneously, thereby increasing the probabil-
ity that they will expand to complete fusion.
We have examined the role of SNARE transmembrane
domains in membrane fusion by replacing the COOH-ter-
minal transmembrane domains of the yeast exocytic
SNAREs Snc2p and Sso2p (Sec9p has no transmembrane
domain) with signals for addition of a geranylgeranyl lipid
anchor. High expression of geranylgeranylated SNAREs
(ggSNAREs) inhibits exocytosis at a stage after SNARE
complex assembly. The secretory block in ggSNARE-
expressing cells can be partially reversed by adding lyso-
phosphatidylcholine (LPC), an inverted cone–shaped lipid
that adds positive curvature to the outer leaflet of the
plasma membrane. Thus, we conclude that SNAREs act at
a late, lipid-sensitive step in membrane fusion and propose
that ggSNAREs cannot catalyze merger of the distal leaf-
lets of the secretory vesicle and plasma membrane.
 
Materials and Methods
 
Plasmids and Strain Construction
 
The 
 
SNC-CIIL
 
 integrating plasmid pNB974 was constructed by PCR amplifi-
cation of 
 
SNC1
 
 using the reverse primer GCCGAAGCTTATCATA-
GAATTATACAACACATCTTCATTTTTAGATC to append sequences
 
coding for CIIL-Stop (underlined) after Cys95. The PCR product was in-
serted between the BamHI and HindIII sites of pNB529, an integrating vec-
tor with a 
 
GAL1
 
 promoter, 
 
ADH1
 
 terminator, and 
 
LEU2
 
 selectable marker.
The 
 
SSO-CIIL
 
 integrating plasmid pNB975 was constructed by PCR amplifi-
cation of 
 
SSO2
 
 using the reverse primer CCAAGCTTATCATAGAA-
TTATACAACATCTTATTTTGTTTTTTCTTGCTTTTCTGGC to ap-
pend sequences coding for CIIL-Stop (underlined) after Cys270. Before
inserting the 
 
SSO-CIIL
 
 PCR product into pNB529, the EcoRI site in the mul-
ticloning site of the vector was mutated by linearizing the plasmid with a par-
tial EcoRI digest, and filling in the overhang using the Klenow subunit of
DNA polymerase I. This mutagenesis allowed pNB975 to be linearized by di-
gestion at the EcoRI site and integrated into the 
 
LEU2
 
 gene.
The
 
 SEC
 
1
 
 host strain SP1
 
a
 
 (
 
MAT
 
a
 
 
 
his3 leu2 trp1 ade8 ura3
 
, NY1705)
was constructed by transient transformation of a plasmid containing the
HO endonuclease to change the mating type of the SP1 strain (Proto-
popov et al., 1993). The 
 
SNC-CIIL
 
 (NY1743) and 
 
SSO-CIIL
 
 (NY1704)
strains were constructed by integration at the 
 
LEU2
 
 locus of SP1
 
a
 
. A
yeast genomic library created by partial digestion of DBY939 genomic
DNA with Sau3A and subcloning into yEP24 was used for the high-copy
suppression screen. Other plasmid tested for suppression included the
empty vector control (pRS426), pNB139 (
 
SEC4 CEN URA3
 
) and 2
 
m
 
URA3
 
 plasmids with the 
 
SEC1
 
 (pNB680), 
 
SEC9
 
 (pNB592), 
 
SEC17
 
(pSFN194), 
 
SEC18
 
 (pSFN199), 
 
SSO2
 
 (BVS), and 
 
SNC2
 
 (from the ge-
nomic library) genes.
Green fluorescent protein (GFP)-Sec1p fluorescence was observed in
SP1
 
a
 
 (NY1746), 
 
SNC-CIIL
 
 (NY1747), and 
 
SSO-CIIL
 
 (NY1748) strains
transformed with pNB828 (Carr et al., 1999). The HA-tagged 
 
SSO2
 
 ex-
pressed in the 
 
sec18-1 HA-SSO2
 
 strain (
 
MAT
 
a
 
 sec18-1 HA-SSO2 ura3
leu2 his3
 
, NY1749) was constructed by the method of Schneider and col-
leagues (Schneider et al., 1995; Carr et al., 1999) in an L-a virus-free host
strain. The 
 
sec5 SSO-CIIL 
 
strain (NY1272) was created by a genetic cross
of NY504 (
 
MAT
 
a
 
 
 
sec5-24 ura3 his4
 
) with SSO-CIIL transformed NY605
(
 
MAT
 
a
 
 leu2 ura3
 
). Strains were grown in media supplemented with 4%
galactose, 4% raffinose, or 2% dextrose.
 
Glycerol Gradients
 
40 
 
A
 
600
 
 units of yeast were lysed with glass beads in HKDNE buffer as de-
scribed previously (Grote and Novick, 1999). 200 
 
m
 
l of cleared lysate (4
mg/ml) was layered over a linear 10–35% glycerol gradient in HKDNE
and spun at 300,000 
 
g
 
 (at 
 
R
 
max
 
) for 5.3 h in an SW50.1 rotor (Beckman
Coulter) at 4
 
8
 
C. 620-
 
m
 
l fractions were collected from the bottom of the
gradient. The gradient fractions were diluted with an equal volume of
HKDNE, and HA-Sso2p was collected by immunoprecipitation with the
12CA5 anti-HA monoclonal antibody. A parallel gradient was run with
gel filtration markers (Bio-Rad Laboratories). Thyroglobulin (670 kD,
19S) sedimented to fraction 4.
 
Secretion Assays
 
Secretion of 
 
35
 
S-labeled proteins was measured by a modification of the
method of Gaynor and Emr (1997). 1.5 
 
A
 
600
 
 units of yeast cells from me-
thionine-free medium were resuspended in 400 
 
m
 
l of methionine-free me-
dium supplemented with 150 
 
m
 
Ci [
 
35
 
S]-ProMix™ cell labeling mix (Amer-
sham Pharmacia Biotech) and labeled for 5 min at 30
 
8
 
C or 37
 
8
 
C as
indicated. The labeling period was stopped by the addition of 44 
 
m
 
l 10
 
3
 
chase medium containing 7 mg/ml methionine, 4 mg/ml cysteine, 0.6 mg/
ml BSA, and 10 mM PMSF. When indicated, freshly dissolved LPC
(Avanti Polar Lipids, Inc.) was added to a final concentration of 0.3 mM.
To collect secreted proteins, the cells were pelleted and 400 
 
m
 
l of superna-
tant was added to 40 
 
m
 
l of 100% TCA, 1 mg/ml deoxycholate, and precip-
itated for at least 30 min on ice. The precipitates were washed twice with
acetone (
 
2
 
20
 
8
 
C), air dried, resuspended in Laemmli sample buffer, boiled
for 5 min, and run on a 10% SDS-polyacrylamide gel. 
 
35
 
S-labeled proteins
were quantified using a Storm™ system (Molecular Dynamics).
 
Other Methods
 
Glutathione 
 
S
 
-transferase (GST)-Snc-CIIL and GST-Sso-CIIL were puri-
fied from 
 
Escherichia coli
 
 and labeled with 
 
3
 
H-GGPP by the method of
Jiang et al. (1993). Procedures for SNARE coimmunoprecipitation and
immunoblotting have been described previously (Grote and Novick,
1999). GFP-Sec1p visualization followed the method of Carr et al. (1999)
as modified (Grote et al., 2000, this issue). FM4-64 endocytosis was ob-
served by the method of Vida and Emr (1995). CPY maturation was mea-
sured by the method of Govindan et al. (1995) except that the samples
were not frozen and thawed before lysis. Immunofluorescent staining of
Sec4p was by the method of Walch-Solimena et al. (1997) using a 63
 
3
 
 ob- 
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jective. Samples were prepared for electron microscopy as described pre-
viously (Baba et al., 1997), and ultrathin sections were examined with a
Hitachi H-800 electron microscope at 125 kV.
 
Results
 
Dominant-negative Lipid-anchored SNAREs
 
As a test of the role of SNARE transmembrane domains
in the process of membrane fusion, we replaced the
COOH-terminal transmembrane domain of the v-SNARE
Snc2p with a CIIL signal coding for addition of a gera-
nylgeranyl isoprenyl group (Moores et al., 1991). To dem-
onstrate activity of the CIIL signal, we compared incorpo-
ration of [
 
3
 
H]geranylgeranyl pyrophosphate into Snc-CIIL
and the soluble cytoplasmic domain of Snc2p. Snc-CIIL
was purified as an NH
 
2
 
-terminal tagged GST fusion
protein from 
 
E. coli
 
. In the presence of lysate from wild-
type yeast expressing type II geranylgeranyltransferase,
[
 
3
 
H]geranylgeranyl pyrophosphate was attached to the
COOH terminus of Snc-CIIL, but not to the unmodified
Snc2p cytoplasmic domain or to COOH-terminally trun-
cated proteolytic fragments of Snc-CIIL (Fig. 1 a).
The 
 
SNC-CIIL
 
 gene was inserted behind a 
 
GAL1
 
 pro-
moter in a yeast integrating vector and integrated at the
 
LEU2
 
 locus of 
 
SEC
 
1
 
 yeast. Expression of the native Snc1
and Snc2 proteins was not perturbed in the 
 
SNC-CIIL
 
transformed strain (data not shown). To determine if re-
placing the transmembrane domain of Snc2p altered its in-
tracellular targeting, we observed the intracellular distri-
bution of Snc-CIIL by subcellular fractionation and
immunofluorescent microscopy. In the first approach,
wild-type control cells and cells expressing Snc-CIIL were
lysed in detergent-free buffer, and the homogenates were
fractionated by standard methods including differential
centrifugation, velocity sedimentation in glycerol gradi-
ents, and sedimentation and floatation to equilibrium den-
sity on sucrose gradients. By all four fractionation meth-
ods Snc-CIIL, which migrates more rapidly than wild-type
Sncp on polyacrylamide gels, was observed in the same
fractions as the native Snc proteins. Furthermore, Snc-
CIIL expression did not significantly alter the fraction-
ation pattern of wild-type Sncp at an early time point after
inducing expression by shifting to galactose medium (data
not shown). Immunofluorescent staining of highly ex-
pressed Snc-CIIL with anti-Sncp antibodies was compared
with the less intense staining pattern of Sncp in wild-type
cells. In both cell types, labeling was observed on the cell
surface and on punctate structures in the cytoplasm (data
not shown). When 
 
snc
 
D
 
 cells were stained with anti-Snc
antibodies, only weak background fluorescence was ob-
served. We conclude that geranylgeranylation of Sncp is
sufficient for membrane attachment and does not disturb
the normal targeting of Sncp to secretory vesicles and the
plasma membrane. Snc-CIIL is probably transported to
the plasma membrane via the conventional secretory path-
way after posttranslational insertion into the ER like the
prenylated protein N-Ras (Choy et al., 1999).
Induction of high-level Snc-CIIL expression with galac-
tose significantly reduced the growth rate of 
 
SNC-CIIL
 
cells compared with wild-type controls. However, if 
 
SNC-
CIIL
 
 cells were grown for several generations in YP glu-
cose medium before plating on YP galactose plates, spon-
taneous revertants were frequently observed. Snc-CIIL
expression was measured in the parent strain and in 60
spontaneous revertants by Western blotting. In the parent
strain, after 8 h induction with galactose the amount of
Snc-CIIL expressed was at least five times greater than the
combined expression level of the native Snc1 and Snc2
proteins. By contrast, Snc-CIIL expression was lost in 59
of 60 spontaneous revertants. The expression level of Snc-
CIIL in the remaining revertant was reduced to a level
equivalent to that of the native Snc proteins. Thus, Snc-
CIIL is a dose-dependent inhibitor of growth.
In an attempt to identify Sncp interacting proteins, we
screened a multicopy genomic library for genes that sup-
press 
 
SNC-CIIL
 
 when overexpressed. 10 suppressing plas-
mids were isolated. Five of these plasmids contained either
the
 
 SNC1
 
 or 
 
SNC2
 
 genes. The remaining plasmids inter-
fered with Snc-CIIL expression. We conclude that the crit-
Figure 1. (a) Geranylgeranylation of Snc-CIIL and Sso-CIIL.
GST-Snc-CIIL, GST-Sso-CIIL, and a 1:1 mixture of the Snc2p and
Sso1p cytoplasmic domains were incubated with wild-type yeast ly-
sate and [3H]geranylgeranyl pyrophosphate for 30 min at 308C.
The reactions were run on a polyacrylamide gel, and geranylgera-
nylated products were detected by autoradiography. Only 10% of
the GST-Sso-CIIL sample was loaded on the gel exposed for auto-
radiography. The input proteins were run on a second gel and
stained with Coomassie blue. Only the full-length GST–Snc-CIIL
protein at 38 kD contains the COOH-terminal CIIL signal; degra-
dation products were not labelled with 3H-GGPP. (b) Growth phe-
notype and suppression of strains expressing Snc-CIIL and Sso-
CIIL. SNC-CIIL and SSO-CIIL under regulatory control of a
GAL1 promoter were integrated at the LEU2 locus of SEC1
yeast (SP1). The control, SNC-CIIL, and SSO-CIIL strains were
then transformed with URA3 episomal plasmids directing overex-
pression of potential interacting proteins. The transformants were
stamped onto synthetic complete (SC) galactose 2 uracil plates
and grown for 5 d at 308C. 
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ical parameter for Snc-CIIL toxicity is the ratio of Snc-
CIIL to wild-type Sncp expressed.
To compare the role of v-SNARE and t-SNARE trans-
membrane domains, we replaced the COOH-terminal
transmembrane domain of the t-SNARE Sso2p with a ger-
anylgeranylation signal. GST-Sso-CIIL, but not the cyto-
plasmic domain of Sso2p, could be labeled in vitro with
[
 
3
 
H]geranylgeranyl pyrophosphate in the presence of gera-
nylgeranyltransferase from a yeast lysate (Fig. 1 a). High-
level Sso-CIIL expression is an even stronger inhibitor of
growth than high level Snc-CIIL expression. In contrast, a
high level expression of the soluble cytoplasmic domain of
Sso2p did not inhibit growth, emphasizing the importance
of membrane attachment by the lipid anchor. To compare
the mechanism of growth inhibition by Snc-CIIL and Sso-
CIIL, we directly tested for suppression of the two mutants
by overexpressing proteins likely to interact with Sncp and
Ssop (Fig. 1 b). We found that 
 
SNC2
 
 suppresses 
 
SNC-CIIL
 
but not 
 
SSO-CIIL
 
, whereas 
 
SSO2
 
 suppresses 
 
SSO-CIIL
 
but not 
 
SNC-CIIL
 
. Thus, for Sso-CIIL as well as Snc-CIIL,
a high ratio of geranylgeranylated to wild-type SNARE
protein is implicated in the growth inhibition. Plasmids di-
recting overexpression of other known SNARE complex
interacting proteins, including Sec9p, Sec1p, Sec17p, or
Sec18p, did not suppress either 
 
SNC-CIIL
 
 or 
 
SSO-CIIL
 
.
In addition, Sec4p overproduction, which suppresses most
of the post-Golgi–blocked temperature-sensitive 
 
sec
 
 alleles
(Salminen and Novick, 1987), did not suppress 
 
SNC-CIIL
 
or 
 
SSO-CIIL
 
. Thus, the ggSNAREs are not inhibiting
 
growth by titering out other components known to interact
with exocytic SNARE proteins.
One caveat concerning the interpretation of these re-
sults is that overexpression of wild-type t-SNAREs inhib-
its membrane transport in several other systems (Dascher
et al., 1994; Bittner et al., 1996; Wu et al., 1998). Consistent
with these reports, we found that massive overproduction
of Sso2p from a 
 
GAL1
 
 promoter partially inhibited
growth (data not shown). However, since moderate over-
production of Sso2p from a multicopy plasmid suppressed
the growth defect of an
 
 SSO-CIIL
 
 strain, wild-type Sso2p
and Sso-CIIL must inhibit growth by distinct mechanisms.
 
SNARE Complex Assembly with ggSNAREs
We next tested whether the ggSNAREs assemble into
SNARE complexes. Replacing the transmembrane do-
mains of Sncp and Ssop with lipid anchors does not alter
the domains essential for SNARE complex assembly in
vitro, but assembly in yeast is subject to additional levels
of regulation. We have previously documented that z1%
of the total Ssop in SEC1 cells coimmunoprecipitates with
Sncp and a similar fraction of the total Sncp coprecipitates
with Ssop (Grote and Novick, 1999). Coimmunoprecipita-
tion is a valid measure of SNARE complex assembly dur-
ing exocytosis because the amount of Ssop coprecipitated
with Sncp is reduced in mutant yeast strains with defects
that prevent secretory vesicle docking with the plasma
membrane (Grote and Novick, 1999; Grote et al., 2000,
Figure 2. Assembly of gg-
SNAREs into SNARE com-
plexes. (a) Coimmunoprecipi-
tation of Snc-CIIL and Sncp
with Ssop. Ssop was immuno-
precipitated from cleared de-
tergent lysates of wild-type
and  SNC-CIIL cells grown in
YP galactose for 4 h at 308C.
Sncp and Snc-CIIL coprecipi-
tating with Ssop and in 1% of
the volume of lysate used for
each immunoprecipitate were
detected by immunoblotting.
(b) Coimmunoprecipitation of
Sso-CIIL and Ssop with Snc.
Sncp was immunoprecipitated
from cleared detergent lysates
of wild-type and SSO-CIIL
cells. Ssop and Sso-CIIL co-
precipitating with Sncp and in
1% of the volume of lysate
used for each immunoprecipi-
tate were detected by immu-
noblotting. (c) Addition of
ATP to lysates prevents copre-
cipitation of Snc-CIIL and Sncp with Ssop. Two lysates were prepared from SNC-CIIL cells grown for 4 h in YP galactose. For the con-
trol lysate, cells were collected in ice-cold Tris (pH 7.5) buffer containing 20 mM NaN3 and 20 mM NaF to deplete intracellular pools of
ATP and lysed in buffer containing 1 mM EDTA as in a and b above. For the 1ATP lysate, cells were collected in buffer without NaN3
or NaF and lysed in buffer with 2.5 mM ATP, 2 mM MgCl2, and an ATP regenerating system. Sncp and Snc-CIIL coimmunoprecipitat-
ing with Sso were detected by immunoblotting as above. (d) SNARE complex levels in wild-type and sec5-24 mutant cells. SSO-CIIL,
sec5-24, and sec5-24 SSO-CIIL double mutant cells were grown in YP galactose plus raffinose for 3 h at 258C to induce low level expres-
sion of Sso-CIIL and then shifted to 378C for 30 min. Ssop and Sso-CIIL coprecipitating with Sncp were detected by immunoblotting
and quantified by densitometry. The expression levels of Sncp and Ssop were equal in each strain, and the expression level of Sso-CIIL
was equal in the wild-type and sec5-24 mutant strains.Grote et al. Lipid-anchored SNAREs Inhibit Fusion 457
this issue). Immunoprecipitation of Ssop from cells ex-
pressing Snc-CIIL resulted in coimmunoprecipitation of
both Snc-CIIL and wild-type Sncp (Fig. 2 a). Similarly, im-
munoprecipitation of Sncp from cells expressing Sso-CIIL
resulted in coimmunoprecipitation of both Sso-CIIL and
wild-type Ssop (Fig. 2 b). One way that ggSNAREs might
inhibit secretion is by competing with wild-type SNARE
proteins for assembly into SNARE complexes. Interest-
ingly, Snc-CIIL expression did not affect the amount of
native Sncp associated with Ssop, and Sso-CIIL expression
did not affect the amount of native Ssop associated with
Sncp. Thus, cells expressing ggSNAREs contain wild-type
as well as mutant SNARE complexes.
The NSF ATPase disassembles SNARE complexes (Soll-
ner et al., 1993a). In yeast, we and others have observed that
addition of ATP and an ATP regenerating system to lysates
induces disassembly of SNARE complexes by the NSF ho-
mologue Sec18p (Ungermann et al., 1998a; Carr et al.,
1999). To test whether geranylgeranylation of SNAREs in-
hibits SNARE complex disassembly, we prepared lysates
with and without ATP from SNC-CIIL cells. Neither Sncp
nor Snc-CIIL coprecipitated with Ssop in lysates prepared
under SNARE disassembly (1ATP) conditions (Fig. 2 c).
Therefore, the geranylgeranyl membrane anchor does not
interfere with SNARE complex disassembly in lysates.
Exocytic SNARE complex assembly depends on contin-
ued traffic through the secretory pathway (Grote and
Novick, 1999). Thus, SNARE complexes fail to assemble
at 378C in the sec5-24 temperature-sensitive mutant
(Grote et al., 2000). Since Sec5p is a component of the
exocyst complex that tethers secretory vesicles to the
plasma membrane (TerBush et al., 1996; Guo et al., 1999),
we concluded that vesicle tethering is required for exocytic
SNARE complex assembly. To determine if vesicle tether-
ing is also required for the assembly of SNARE complexes
containing Sso-CIIL, we observed SNARE complexes in a
sec5-24 SSO-CIIL strain. To avoid complications arising
from the dominant-negative effects of high-level Sso-CIIL
expression, the experiment was performed at an early time
point after galactose addition before Sso-CIIL had a mea-
surable effect on the growth rate. In addition, raffinose
was included in the induction medium to reduce Sso-CIIL
expression and minimize the disruptive effect of changing
carbon sources. A 30% reduction in the binding of Ssop to
Sncp was observed in sec5-24 cells after shifting to 378C in
YP galactose plus raffinose. This effect is small compared
with the 90% reduction in SNARE complex levels ob-
served in the same cells grown in YP glucose (Grote et al.,
2000). In the absence of glucose, a reduced growth rate
and partial translocation of Ssop from the plasma mem-
brane to intracellular vesicles (data not shown) may con-
tribute to the reduced response of SNARE complexes to
the temperature shift. Nevertheless, when sec5-24 SSO-
CIIL cells were shifted to 378C, there was a reduction in
binding of both Sso-CIIL and Ssop to Sncp, and this reduc-
tion was equivalent to the reduction in binding of Ssop to
Sncp in sec5-24 cells not expressing Sso-CIIL. Further-
more, binding of Sso-CIIL to Sncp was not reduced at
378C in a SEC5 SSO-CIIL strain (Fig. 2 d). Because the
sec5-24 mutation has equivalent effects on SNARE com-
plexes containing Sso-CIIL and wild-type Ssop, we con-
clude that tethering of secretory vesicles to the plasma
membrane precedes the assembly of SNARE complexes
between Sncp and Sso-CIILp at the plasma membrane.
Sec1p binds to assembled Sncp/Ssop/Sec9p SNARE
complexes and is targeted to sites of exocytosis in the tips
of emerging buds and at mother–daughter necks in divid-
ing cells (Carr et al., 1999). The fluorescence pattern of
GFP-Sec1p was observed in SNC-CIIL and SSO-CIIL
cells to determine the effect of ggSNARE expression on
Sec1p targeting. Expression of Snc-CIIL or Sso-CIIL did
not interfere with the targeting of GFP-Sec1p to bud tips
and necks. However, the region of bright GFP-Sec1p fluo-
rescence extended over a larger area of the plasma mem-
brane within the bud in ggSNARE-expressing cells (Fig.
3). Since the peak intensity was similar in wild-type and
mutant cells, the total amount of GFP-Sec1p targeted to
the plasma membrane in the bud appears to be greater in
the mutant cells. Coimmunoprecipitation of Sec1p with
SNARE complexes was also enhanced by ggSNARE ex-
pression (see below, and data not shown). Thus, Sec1p in-
teracts with SNARE complexes containing ggSNAREs.
Figure 3. GFP-Sec1p fluorescence. GFP was integrated at the 59 end of the SEC1 gene in wild-type, SNC-CIIL, and SSO-CIIL cells.
Transformants were grown to early log phase in YP raffinose and then transferred to YP galactose medium for 4 h at 308C. The cells
were fixed with methanol to enhance the GFP signal.The Journal of Cell Biology, Volume 151, 2000 458
Higher-Order SNARE Complex Assembly
SNARE proteins isolated from rat brains are found in 7S
heterotrimeric VAMP/syntaxin/SNAP-25 complexes. 20S
SNARE complexes are formed upon the addition of recom-
binantly expressed a-SNAP and NSF (Sollner et al., 1993a).
To examine the sedimentation rate of yeast exocytic
SNAREs, a detergent-solubilized yeast lysate was sedi-
mented into a glycerol gradient. Centrifugation conditions
were calibrated so that a 19.6S marker protein (thyroglobu-
lin) sedimented to a peak near the center of the gradient in
fraction 4, and purified recombinant monomeric Ssop cyto-
plasmic domain (Rice et al., 1997) was recovered from the
top three fractions. The lysate was prepared from sec18-1
cells shifted to 378C before lysis to maximize the percentage
of SNAREs incorporated into SNARE complexes. The ma-
jority of the Sncp, Sso1p, and HA-Sso2p sedimented at the
rate expected for monomers, dimers, and small complexes,
but a small percentage of the SNARE proteins sedimented
more rapidly and were broadly distributed in the lower frac-
tions of the gradient (Fig. 4 a).
The percentage of Ssop that sedimented at $20S in the
glycerol gradient was similar to the percentage of Ssop
bound to Sncp. Both rapid sedimentation and coprecipita-
tion are enhanced in a sec18-1 strain upon shift to 378C
and reduced in sec4-8 strains (data not shown). To deter-
mine where SNARE complexes sediment in the glycerol
gradient, HA-Sso2 was immunoprecipitated from an ali-
quot of each gradient fraction with an anti-HA antibody.
The HA-Sso2–bound Sncp was enriched in the more rap-
idly sedimenting fractions, whereas the unbound Sncp sed-
imented as monomer (Fig. 4 b). HA-Sso2p–bound Sec1p
and Sso1p were also enriched in the more rapidly sedi-
menting fractions. Coprecipitation of untagged Sso1p with
HA-Sso2p is especially informative because it suggests
that the rapidly sedimenting SNARE proteins are compo-
nents of higher-order SNARE multimers containing at
least two SNARE heterotrimers. However, since these
SNARE complexes sediment heterogeneously and have
not been purified, it is impossible to determine the precise
stoichiometry of each component or to exclude the possi-
bility that other unidentified proteins may associate with
this pool of SNAREs.
A small fraction of the Sncp, Sec1p, and untagged Ssop
in the top fraction of the glycerol gradient coprecipitated
with HA-Sso2p (Fig. 4 b). These proteins were not present
in a control anti-HA precipitation from the top fraction of
a gradient prepared from an untagged sec18-1 strain (data
not shown). Since myoglobin, a 17-kD globular protein
used as a standard, sedimented to a peak in the second
fraction of an identical gradient (data not shown), the
complexes in the top fraction of the gradient must be asso-
ciated with a buoyant component such as a detergent-
insoluble lipid raft.
If the assembly of SNARE trimers into higher-order
multimers requires hydrophobic interactions mediated by
transmembrane domains (Laage et al., 2000), ggSNAREs
might be excluded from the multimeric SNARE com-
plexes or might limit their assembly. Therefore, assembly
of higher-order SNARE multimers was examined in cells
expressing ggSNAREs. To streamline the assay for higher-
order SNARE complex assembly, we tested for coimmu-
noprecipitation of Sso1p with HA-Sso2p (Fig. 4 c). As
shown above, this interaction occurs primarily within the
rapidly sedimenting complexes. To further validate the as-
say, we compared HA-Sso2p immunoprecipitates from
sec18-1 cells that were either maintained at the permissive
Figure 4. Multimeric SNARE complexes. (a) Sedimentation of
detergent-solubilized yeast proteins on a glycerol velocity gradi-
ent. HA-SSO2 sec18-1 cells were grown to log phase at 258C and
then shifted to 378C for 10 min before lysis in buffer containing
0.5% NP-40. 200 ml of a cleared lysate was loaded on the top of a
5–35% glycerol gradient prepared in 0.5% NP-40 lysis buffer. Af-
ter centrifugation at 300,000 g for 5.3 h, fractions were collected
from the bottom of the gradient. An aliquot of each gradient
fraction was run on an SDS-PAGE gel and probed for Sec1p,
Ssop, and Sncp by immunoblotting. The upper band detected
with the Sec1p antibody is not Sec1p. In an identical gradient run
in parallel, thyroglobulin (19.6S) sedimented to a sharp peak in
fraction 4. (b) Coprecipitation of Sec1p, Sec9p, Sso1p, and Sncp
with HA-Sso2p from the glycerol gradient fractions. HA-Sso2p
was immunoprecipitated from each gradient fraction in a using
an anti-HA monoclonal antibody. (c) Coimmunoprecipitation of
Sec1p, Sso1, and Sncp with HA-SSO2 is enhanced by Snc-CIIL
expression. HA-SSO2 sec18-1, SNC-CIIL HA-SSO2 sec18-1, and
SNC-CIIL sec18-1 cells were grown for 4 h in YP galactose at
258C. The cultures were split in two, and one aliquot was shifted
to 378C for 10 min before lysis. Anti-HA immunoprecipitates and
1% of the lysate were probed for Sec1p, HA-Sso2p, Sso1p, Sncp,
and Snc-CIIL by immunoblotting. The HA-Sso2p band from the
anti-HA immunoprecipitates was dissected away from the Sso1p
band before probing with the anti-Sso antibody.Grote et al. Lipid-anchored SNAREs Inhibit Fusion 459
temperature of 258C or shifted to 378C for 10 min. As ex-
pected, the amount of Sso1p, Sncp, and Sec1p bound to
HA-Sso2 increased when the mutant Sec18-1 protein was
inactivated. When HA-Sso2p was immunoprecipitated
from  SNC-CIIL cells, both Sncp and Snc-CIIL coprecipi-
tated, as shown in Fig. 2. The amount of Sso1p bound to
HA-Sso2p also increased in Snc-CIIL–expressing cells.
Therefore, cells expressing Snc-CIIL have more higher-
order SNARE multimers in addition to more SNARE tri-
mers. Consistent with the GFP-Sec1p fluorescence results
(Fig. 3), the amount of Sec1p bound to HA-Sso2 also in-
creased in the Snc-CIIL–expressing cells. Unexpectedly,
blocking SNARE complex disassembly by shifting sec18-1
SNC-CIIL cells to 378C before lysis resulted in only a
small increase in the amount of Sec1p, Sso1p, and Sncp
bound to HA-Sso2p. Since SNARE complex assembly de-
pends on flux through the secretory pathway (Grote and
Novick, 1999), one interpretation of this result is that an
exocytosis block resulting from Snc-CIIL expression pre-
vents additional SNARE complex assembly.
We also examined sedimentation of SNARE complexes
from SNC-CIIL and SSO-CIIL cells into glycerol gradi-
ents. ggSNARE expression did not affect the sedimenta-
tion behavior of the wild-type SNAREs, and the behavior
of the ggSNAREs and wild-type SNAREs was identical.
In particular, ,2% of the Snc-CIIL and Sso-CIIL sedi-
mented at $20S, but the pools of both Snc-CIIL and Sso-
CIIL in SNARE complexes were highly enriched in the
rapidly sedimenting fractions (data not shown). We con-
clude that assembly of Sncp and Ssop into multimeric
SNARE complexes is unaffected by replacement of the
transmembrane domain with a lipid anchor.
ggSNAREs Inhibit Secretory Vesicle Fusion
Since Sncp and Ssop are implicated in the final stage of se-
cretion, we tested the effect of high level Snc-CIIL and
Sso-CIIL expression on secretion. 6 h after Snc-CIIL in-
duction, cells were metabolically labeled with a 5-min
pulse of [35S]methionine/cysteine and then chased for vari-
ous periods of time. Proteins secreted into the media were
concentrated by TCA precipitation and then separated on
a polyacrylamide gel. The pattern of bands secreted by
wild-type and SNC-CIIL cells was similar, but the rate of
secretion was significantly slower in the SNC-CIIL cells
(Fig. 5). No reduction in protein synthesis was observed.
Similar results were observed for SSO-CIIL as shown be-
low. Thus, the growth inhibitory effects of the ggSNAREs
are coincident with an inhibition of secretion.
Because Sncp binds to several syntaxin-like t-SNAREs
in addition to Ssop (Abeliovich et al., 1998; Holthuis et al.,
1998; Grote and Novick, 1999), we tested whether trans-
port to the vacuole is also inhibited by Snc-CIIL expres-
sion. Newly synthesized carboxypeptidase Y was targeted
to vacuoles and processed to its mature form at the same
rate in wild-type and SNC-CIIL cells after 4 h growth in
galactose medium (data not shown). Similarly, transport of
the fluorescent dye FM4-64 from the plasma membrane to
vacuoles was normal in SNC-CIIL cells after 4 h growth in
galactose (data not shown). Because secretion is inhibited
at this time point by 50% in SNC-CIIL cells, we conclude
that exocytosis is the first transport step to be inhibited by
Snc-CIIL expression. However, after 10 h growth in galac-
tose medium, FM4-64 was internalized, but was not trans-
ported to a single large vacuole (data not shown). This
endocytic defect may be either a direct consequence of
Snc-CIIL binding to endocytic t-SNAREs (Grote and No-
vick, 1999) or an indirect effect of the block in secretion.
To determine which stage of the secretory pathway is in-
hibited by ggSNARE expression, we began with testing
for vesicle targeting by immunofluorescent staining of the
vesicle-associated Rab GTPase Sec4p. Vesicle targeting
defects in mutants that affect the actin cytoskeleton or
prevent nucleotide exchange on Sec4p result in a loss of
polarized Sec4p immunofluorescent staining (Walch-Soli-
mena et al., 1997). In SNC-CIIL and SSO-CIIL cells,
Sec4p fluorescence is concentrated in bud tips and
mother–daughter necks as it is in SEC1 yeast (Fig. 6).
However, Sec4p staining is more intense and fills a larger
area of the cytosol in the mutant cells. Thus, ggSNAREs
Figure 5. SNC-CIIL inhibits secretion. Snc-CIIL expression was
induced for 6 h in SC galactose medium without methionine at
258C. Cells were labeled for 5 min with [35S]-ProMix, and chased
with excess methionine and cysteine. Aliquots were removed at
the indicated time points and separated into cell pellet and media
fractions by centrifugation. (a) Media proteins collected by TCA
precipitation and (b) cellular proteins released by glass bead lysis
were run on SDS-PAGE gels. Autoradiographs were exposed to
film for 4 d (secreted proteins) and 2 h (2% of lysate). (c) Secre-
tion of the 185-kD protein (arrow in a) was quantified using a
Storm™ PhosphorImaging system.The Journal of Cell Biology, Volume 151, 2000 460
do not inhibit vesicle targeting but may cause an accumu-
lation of vesicles that occupy a large fraction of the bud.
To test for secretory vesicle accumulation more directly,
OsO4/UAc-stained ultrathin sections were observed by
transmission electron microscopy. There was a significant
accumulation of 100-nm secretory vesicles in cells express-
ing Snc-CIIL or Sso-CIIL. We observed the time course of
vesicle accumulation after induction of Sso-CIIL expres-
sion. 1 h after shifting to galactose medium, the small num-
ber (5–30) of vesicles observed were often located adja-
cent to the plasma membrane in the bud. After 2 h
induction, hundreds of vesicles filled the entire bud and
spilled over into the mother cell. At later time points,
other abnormal membrane structures including enlarged
secretory vesicles and Berkeley Bodies, swollen deriva-
tives of the yeast Golgi, were observed (data not shown).
To look at higher resolution for evidence of vesicle
docking, freeze-substituted samples were prepared for
electron microscopy (Fig. 7). On these specimens, vesicles
were often surrounded by a regularly spaced coat struc-
ture that excluded densely staining ribosomes. A small
number of vesicles (five or less per cell cross-section) were
located within 15 nm of the plasma membrane. These vesi-
cles often bulged out towards the plasma membrane, sug-
gesting a strong physical attachment. It is difficult to trace
membranes at sites of contact between vesicles and the
plasma membrane because ultrathin sections are 60-nm
thick, whereas only 10 nm separates the two hydrophilic
layers of phospholipid bilayer membranes. In some in-
stances, distinct secretory and plasma membrane bilayers
can be observed, but these may have been sectioned above
or below the point of contact. In other images, the outer
leaflet of the secretory vesicle and the inner leaflet of the
plasma membrane appear to merge at the intersection
point and in rare cases vanish. These images may repre-
sent the initiation of membrane fusion. No contacts were
found where the outer leaflet of the plasma membrane
and the inner leaflet of the vesicles coalesced to form a sin-
gle extended bilayer. Thus, if exocytosis is arrested at a
hemifusion intermediate in cells expressing ggSNAREs,
the intermediate must either be short-lived or have a di-
ameter less than the thickness of the sections. In addition,
a similar number of vesicles closely apposed to the plasma
membrane were observed in cells expressing the domi-
nant-negative mutant sec4-N34 (data not shown). GTP-
Sec4p is known to be required for vesicle transport to bud
tips (Walch-Solimena et al., 1997) and to bind to Sec15p, a
component of the exocyst tethering complex (Guo et al.,
1999). Furthermore, Sec4-N34 expression inhibits SNARE
complex assembly (Grote and Novick, 1999). It is there-
fore possible that some of the vesicles that appear to be
docked in ggSNARE cells have randomly localized adja-
cent to the plasma membrane.
LPC Rescues Secretion in SNC-CIIL and 
SSO-CIIL Cells
The major difference between the lipid anchors of gg-
SNAREs and the transmembrane domains of wild-type
SNAREs is that a geranylgeranyl group cannot interact
with the hydrophilic portion of the distal leaflet of a phos-
pholipid bilayer, whereas the transmembrane domain
must interact with the distal leaflet because it spans the en-
tire membrane and is followed by a short hydrophilic se-
quence. We reasoned that an agent that increases the fu-
sion potential of the distal leaflet might rescue secretion
from cells expressing ggSNAREs. 10:0 LPC is an inverted
cone–shaped lipid with a bulky, positively charged choline
head group and a single, 10-carbon saturated aliphatic
chain. The choline head group prevents spontaneous
transport of LPC across lipid bilayers, and there is no en-
zymatic LPC flip-flop across the yeast plasma membrane
(Tang et al., 1996). Thus, LPC has the potential to induce
positive curvature in the outer leaflet of the plasma mem-
brane (Sheetz and Singer, 1974).
To assay for LPC-mediated suppression of the exocytic
block, we pulse labeled cells with [35S]methionine/cysteine
and measured secretion of the labeled 185-kD protein
identified in Fig. 5 in the presence or absence of LPC. An
Figure 6. Immunofluorescent labeling of Sec4p in cells expressing Snc-CIIL and Sso-CIIL. Wild-type, SNC-CIIL, and SSO-CIIL cells
were grown in YP galactose for 4 h at 308C before fixation. Fixed cells were permeabilized with 0.1% SDS and then stained for Sec4p by
indirect immunofluorescence. Some of the bud tips are above or below the plane of focus.Grote et al. Lipid-anchored SNAREs Inhibit Fusion 461
advantage of this assay is that effects on exocytosis can be
observed immediately after adding LPC, thereby minimiz-
ing the possibility of being misled by indirect effects. Se-
cretion from both SNC-CIIL (P . 0.90) and SSO-CIIL
(P . 0.99) cells was stimulated upon addition of 0.3 mM
10:0 LPC (Fig. 8 a). Interestingly, LPC stimulated more
35S-p185 secretion from SSO-CIIL cells than from SNC-
CIIL cells. This difference may be related to the fact that
the geranylgeranyl group of Sso-CIIL is embedded in the
plasma membrane where LPC acts.
However, in addition to stimulating secretion from gg-
SNARE-expressing cells, LPC can also inhibit secretion.
Higher concentrations of LPC (.0.6 mM) inhibited secre-
tion from ggSNARE-expressing cells. This inhibition ex-
cludes the possibility that LPC stimulates secretion from
ggSNARE-expressing cells by lysing membranes. Further-
more, the possibility that LPC stimulates exocytosis from
ggSNARE-expressing cells via nonspecific detergent arti-
facts can be excluded because 0.5% Triton X-100 and
Tween 20 have no effect on p185 release (data not shown).
If a large pool of hemifused secretory vesicles accumu-
lates in Sso-CIIL–expressing cells, addition of LPC might
result in a burst of secretion. To test for this effect, the
amount of 35S-p185 release in SSO-CIIL cells was quanti-
fied at three time points after LPC addition (Fig. 8 b). In-
stead of a burst of 35S-p185 release, there was a sustained
increase in the secretion rate. These data suggest that only
a small fraction of the secretory vesicles accumulated in
Figure 7. Ultrastructure of
SNC-CIIL and SSO-CIIL
cells.  SNC-CIIL (a–e) and
SSO-CIIL (f–j) cells were
grown for 2 h in YP galactose
and then prepared for elec-
tron microscopy by freeze-
substitution. Low magnifica-
tion images of a bud (a) and
the septum forming between
dividing mother cells (f)
demonstrate an accumula-
tion of 100-nm secretory ves-
icles, several of which are
closely associated with the
plasma membrane (see ar-
rows). Higher magnification
images (b–e, g–j) of vesicles
adjacent to the plasma mem-
brane are also shown. The
vesicles in d and h evaginate
towards the plasma mem-
brane. Possible merger of the
outer leaflet of the secretory
vesicle with the inner leaflet
of the plasma membrane can
be seen in e. Bars, 100 nm.The Journal of Cell Biology, Volume 151, 2000 462
the SSO-CIIL mutant have reached the stage that is sub-
ject to activation by LPC. This may reflect a limited num-
ber of docking sites and is in agreement with the largely
cytoplasmic distribution of vesicles observed by electron
microscopy (Fig. 7).
Discussion
The SNC-CIIL and SSO-CIIL mutations were designed
by analogy to the GPI-HA mutant of the influenza HA fu-
sion protein to test the hypothesis that SNARE transmem-
brane domains have a critical function in membrane fu-
sion. High expression of Snc-CIIL or Sso-CIIL inhibited
exocytosis, but did not inhibit transport of secretory vesi-
cles to the bud or docking of vesicles to the plasma mem-
brane. Instead, exocytosis was arrested at a late, LPC-sen-
sitive stage. These observations suggest that an interaction
between the transmembrane domain of SNARE proteins
and the distal leaflets of apposed membranes is essential
for fusion.
We propose that a functional SNARE complex must in-
clude at least two transmembrane domains, one for the
vesicle membrane and one for the target membrane. Simi-
larly, viral fusion requires both a transmembrane domain
and a fusion peptide for fusion activity, and mutations in
either domain can result in hemifusion (Kemble et al.,
1993; Qiao et al., 1999). Several SNARE proteins are nat-
urally modified with lipids (Hess et al., 1992; Couve et al.,
1995; McNew et al., 1997; Vogel and Roche, 1999). For ex-
ample, Snc1p is palmitylated on Cys95, the same site that
is geranylgeranylated in Snc-CIIL (Couve et al., 1995).
Nevertheless, neither overexpression of palmitylated
Snc1p nor a snc1-Cys95Ala mutation that prevents palmi-
tylation has a deleterious effect on secretion (Protopopov
et al., 1993; Couve et al., 1995). Thus, Snc-CIIL toxicity
correlates with the lack of a transmembrane domain
rather that the presence of a lipid anchor. Another inter-
esting example is Ykt6p, the Sed5p-associated v-SNARE
implicated in ER to Golgi complex transport and vacuole
fusion (Sogaard et al., 1994; Lupashin et al., 1997; McNew
et al., 1997; Ungermann et al., 1998a). Ykt6p is attached to
vesicles via a COOH-terminal farnesyl group (Sogaard et
al., 1994). Since Ykt6p does not have a transmembrane do-
main, we suggest that Ykt6p incorporates into SNARE
complexes that have a second v-SNARE protein with a
transmembrane domain such as Vti1p.
Snc-CIIL and Sso-CIIL both assemble into SNARE
complexes indistinguishable by several criteria from com-
plexes containing wild-type SNAREs. These complexes
can assemble into higher-order multimers, recruit GFP-
Sec1p to bud tips, and be disassembled by Sec18p. Never-
theless, ggSNAREs do not interfere with the assembly of
wild-type SNARE proteins into complexes. Therefore, it
is the presence of the mutant SNARE complexes rather
than the absence of wild-type complexes that is responsi-
ble for the inhibition of exocytosis. Assembly of Sso-CIIL
into SNARE complexes indicates that vesicles have
docked to the plasma membrane because the temper-
ature-sensitive  sec5 mutation inhibited assembly of
SNARE complexes containing Sso-CIIL as well as native
Ssop. Sec5p is a component of the exocyst complex that is
thought to tether secretory vesicles to the plasma mem-
brane before SNARE complex assembly (Guo et al., 1999;
Grote et al., 2000). Because only a short span of amino ac-
ids separates the transmembrane domains of Sncp and
Ssop from their SNARE complex forming a-helical do-
mains, the completion of SNARE complex assembly
should bring the two membranes into close proximity and
may also distort the membranes at the point of contact
leading to the initiation of fusion (Sutton et al., 1998).
One mechanism for ggSNAREs to inhibit fusion with-
out affecting the assembly of normal SNARE complexes is
by poisoning the function of a higher-order SNARE com-
plex. In support of this model, we found that the majority
of the exocytic SNARE complexes in a yeast lysate sedi-
ment at .20S. These rapidly sedimenting complexes must
contain at least two copies of Ssop because untagged
Sso1p coimmunoprecipitates with HA-Sso2p from frac-
tions near the bottom of the gradient. Furthermore, these
higher-order SNARE complexes are likely to have assem-
bled in vivo rather than in the lysate because if different
populations of cells expressing myc-Ssop and HA-Sncp
are mixed before lysis, the myc-Ssop and HA-Sncp do not
bind to each other in vitro (Carr et al., 1999). Because Snc-
CIIL toxicity requires a high ratio of Snc-CIIL to wild-
type Sncp expression, higher-order SNARE complexes
Figure 8. LPC-stimulated secretion. (a) SNC-CIIL and SSO-
CIIL cells were pulse labeled for 5 min with [35S]-ProMix, chased
for 5 min with excess methionine, and then stimulated with 0.3
mM LPC. Secretion of 35S-p185 was quantified (error bars indi-
cate SEM, n 5 3). Secretion from wild-type cells not treated with
LPC was defined as 100%. (b) Kinetics of secretion from LPC-
stimulated cells. SSO-CIIL cells were pulse labeled for 5 min
with [35S]-ProMix, chased for 5 min, and then LPC was added for
the indicated times. Secretion of p185 was quantified.Grote et al. Lipid-anchored SNAREs Inhibit Fusion 463
may retain partial function if only a minority of the Snc
proteins have lipid anchors. Similarly, viral fusion involves
cooperative interactions between multiple HA trimers
(Blumenthal et al., 1996; Danieli et al., 1996), but based on
theoretical calculations, less than half of these HA trimers
must undergo a conformational shift for fusion to occur
(Bentz, 2000).
To test the hypothesis that ggSNAREs and GPI-HA are
defective at a similar stage of fusion, we tested whether
LPC would stimulate exocytosis. LPC, which induces posi-
tive curvature in the outer leaflet of the plasma mem-
brane, stimulated secretion from ggSNARE-expressing
cells. Similarly, chlorpromazine, which induces positive
curvature in the inner leaflet of the plasma membrane,
stimulates fusion of GPI-HA–expressing fibroblasts with
red blood cells (Melikyan et al., 1997; Chernomordik et al.,
1999). In the absence of chlorpromazine, GPI-HA medi-
ates hemifusion, the fusion of the proximal leaflets of two
membranes but not their distal leaflets. Thus, our data
support the model that ggSNAREs are defective at the fi-
nal stage of exocytic fusion—the merging of the inner leaf-
let of the secretory vesicle with the outer leaflet of the
plasma membrane (Fig. 9). However, because it is not pos-
sible to selectively label the outer leaflet of secretory vesi-
cles with a fluorescent marker in living cells, there is no de-
finitive evidence that ggSNAREs induce hemifusion.
Also, in contrast to the consistent observation that LPC
stimulates secretion from ggSNARE-expressing cells, in
wild-type cells LPC slightly inhibited secretion in some ex-
periments and stimulated secretion in others. These dis-
parate results suggest that the transition from hemifusion
to complete fusion may be rate limiting in wild-type cells
under appropriate conditions.
We considered several alternative explanations for the
mechanism of LPC stimulation. LPC might interact with
proteins rather than lipids (Gunther-Ausborn et al., 1995).
Since LPC inhibits several enzymes including adenyl cy-
clase in yeast (Resnick and Tomaska, 1994), it is possible
that LPC stimulates fusion by interacting with a protein.
However, LPC does not cross the yeast plasma membrane
(Tang et al., 1996), so it would not have access to cytoplas-
mic proteins including those involved in membrane fusion.
Although LPC might exert effects on the cytoplasmic side
of the plasma membrane via a cell surface receptor, there
is no evidence for LPC receptors or ligand-stimulated exo-
cytosis in yeast.
LPC stimulated release of 58% of the accumulated 35S-
p185 in SSO-CIIL cells and 16% in SNC-CIIL cells. Per-
haps, the effectiveness of LPC is limited by our experi-
mental system. First, LPC has direct access to only one
leaflet of the putative hemifusion diaphragm. LPC might
enter the inner leaflet of secretory vesicles after recycling
from the plasma membrane to the Golgi by endocytosis,
but this LPC cannot stimulate 35S-p185 release in our ex-
periments because secretory vesicles are loaded with 35S-
p185 before the addition of LPC. Second, there is a mas-
sive buildup of secretory vesicles in the cells before the
35S–amino acid pulse. These vesicles are likely to be se-
questering some of the components involved in vesicle tar-
geting and fusion. For comparison, addition of 0.4 mM
chlorpromazine to a GPI-HA fusion assay resulted in full
fusion of only 36% of the cells (Melikyan et al., 1997).
Thus, we consider the partial rescue of secretion by LPC
to be highly significant.
One unresolved question is why a large number of
SNARE complexes, docked secretory vesicles, and per-
haps hemifusion intermediates, did not accumulate in the
ggSNARE-expressing cells if secretion is blocked at a
stage after vesicle docking. One possibility is that docking
and hemifusion are reversible. Interestingly, a reversible
hemifusion intermediate has been detected for hemifusion
catalyzed by HA (Leikina and Chernomordik, 2000).
However, there is some evidence that SNARE complex
assembly is not reversible. If sec5-24 SSO-CIIL cells are
grown for 11 h in YP galactose to completely inhibit secre-
tion, there is no reduction in SNARE complex levels upon
shifting to 378C (our unpublished observation). Since
Sec5p is required for assembly of exocytic SNARE com-
plexes, and SNARE complex levels do not decrease in this
situation, there must also be no SNARE complex disas-
sembly. The implication of this result is that there is a
small, stable population of docked secretory vesicles
rather than a continuous cycle of vesicle docking and un-
docking. An alternative explanation for the failure of
docked vesicles to accumulate is that there are a limited
number of secretory vesicle docking sites on the plasma
Figure 9. Model of LPC in-
corporation into the outer
leaflet of the plasma mem-
brane in ggSNARE cells
arrested in hemifusion.
The transmembrane domains
of Snc-CIIL and Sso-CIIL
(boxes) have been replaced
by a geranylgeranyl lipid
anchor (line). Snc-CIIL
and Sso-CIIL assemble into
SNARE complexes via inter-
actions between their a-heli-
cal domains (hatched boxes).
Assembly of these mutant SNARE complexes promotes hemifusion wherein the outer leaflet of the secretory vesicle fuses with the in-
ner leaflet of the plasma membrane, but the distal leaflets remain distinct. Once hemifusion occurs, the lipidic anchors on Snc-CIIL and
Sso-CIIL are free to diffuse across the lipidic stalk connecting the two membranes (arrows) and are thus unable to catalyze merger of
the distal leaflets. LPC (L) added to the medium incorporates into the outer leaflet of the plasma membrane and promotes positive cur-
vature in one leaflet of the hemifusion diaphragm. This positive curvature reduces the activation energy for fusion of the distal leaflets,
thereby stimulating completion of the exocytic reaction.The Journal of Cell Biology, Volume 151, 2000 464
membrane. Since there are large unassembled pools of all
of the known secretory proteins (SNAREs, Sec1p, the
exocyst, and Sec4p), availability of these proteins is not
likely to be limiting for vesicle docking. Thus, we suggest
that the number of docking sites is limited either by an un-
known component or by a sensor of assembled SNARE
complexes that negatively regulates vesicle docking.
The hypothesis that SNAREs catalyze membrane fusion
has been challenged by two groups who have reported that
SNARE complexes can be disassembled before mem-
brane fusion (Coorssen et al., 1998; Tahara et al., 1998;
Ungermann et al., 1998b). They have proposed that
SNAREs stabilize vesicle docking and recruit other fac-
tors that catalyze fusion. We find that ggSNAREs assem-
ble into SNARE complexes, dock secretory vesicles to
plasma membrane, and recruit GFP-Sec1p to exocytic
sites, yet still block fusion. To conform to the alternative
hypothesis, the transmembrane domains of both Sncp and
Ssop must be essential to recruit the alternative fusion
protein. Thus, our data are more consistent with the model
that SNARE complexes directly catalyze fusion.
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